Literature DB >> 15681503

Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.

S Mori1, A Mizoguchi, M Kawabata, H Fukunaga, K Usuku, I Maruyama, M Osame.   

Abstract

BACKGROUND: A study was undertaken to investigate the pathogenesis of pulmonary involvement in human T lymphotropic virus type I (HTLV-I) carriers.
METHODS: The bronchoalveolar lavage (BAL) cell profile of 30 HTLV-I carriers (15 asymptomatic HTLV-I carriers (AHCs) and 15 symptomatic HTLV-I carriers (SHCs)) with chronic inflammatory diseases of respiratory tract and eight patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) was investigated. The HTLV-I proviral deoxyribonucleic acid (DNA) load in peripheral blood mononuclear cells (PBMCs) and BAL fluid from HTLV-I carriers was estimated using the quantitative polymerase chain reaction method and the correlation between the lymphocyte number in BAL fluid and the HTLV-I proviral DNA load in PBMCs and BAL fluid was examined.
RESULTS: The percentage of lymphocytes in BAL fluid was increased (>18%) in 11 of 30 HTLV-I carriers although there was no significant difference compared with control subjects. In HTLV-I carriers the lymphocyte number in BAL fluid correlated well with the copy number of HTLV-I proviral DNA in PBMCs. In addition, the copy number of HTLV-I proviral DNA in BAL fluid correlated well with the number of lymphocytes (both CD4+ and CD8+ cells) in BAL fluid.
CONCLUSIONS: These findings suggest that pulmonary lymphocytosis can occur in a subset of HTLV-I carriers without HAM/TSP and that the increased HTLV-I proviral DNA load may be implicated in the pathogenesis of pulmonary involvement in HTLV-I carriers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681503      PMCID: PMC1747290          DOI: 10.1136/thx.2004.021667

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  32 in total

1.  Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

Authors:  Elliot Israel; Vernon M Chinchilli; Jean G Ford; Homer A Boushey; Reuben Cherniack; Timothy J Craig; Aaron Deykin; Joanne K Fagan; John V Fahy; James Fish; Monica Kraft; Susan J Kunselman; Stephen C Lazarus; Robert F Lemanske; Stephen B Liggett; Richard J Martin; Nandita Mitra; Stephen P Peters; Eric Silverman; Christine A Sorkness; Stanley J Szefler; Michael E Wechsler; Scott T Weiss; Jeffrey M Drazen
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

2.  Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1.

Authors:  M Seki; Y Higashiyama; J Kadota; H Mukae; K Yanagihara; K Tomono; S Kohno
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

3.  Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.

Authors:  E Hanon; J C Stinchcombe; M Saito; B E Asquith; G P Taylor; Y Tanaka; J N Weber; G M Griffiths; C R Bangham
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

4.  CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I.

Authors:  M Nagai; M B Brennan; J A Sakai; C A Mora; S Jacobson
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

5.  Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.

Authors:  M Nagai; Y Yamano; M B Brennan; C A Mora; S Jacobson
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

6.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

7.  Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells.

Authors:  M Osame; M Matsumoto; K Usuku; S Izumo; N Ijichi; H Amitani; M Tara; A Igata
Journal:  Ann Neurol       Date:  1987-02       Impact factor: 10.422

8.  Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.

Authors:  M Kannagi; K Sugamura; H Sato; K Okochi; H Uchino; Y Hinuma
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  13 in total

1.  Multiplex Droplet Digital PCR Assay for Quantification of Human T-Cell Leukemia Virus Type 1 Subtype c DNA Proviral Load and T Cells from Blood and Respiratory Exudates Sampled in a Remote Setting.

Authors:  David Yurick; Georges Khoury; Bridie Clemens; Liyen Loh; Hai Pham; Katherine Kedzierska; Lloyd Einsiedel; Damian Purcell
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

Review 2.  Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjögren's syndrome, three case reports and literature review.

Authors:  Hui Yu; Futoshi Higa; Ichiro Yamadori; Satomi Yara; Yasushi Tanimoto; Shusaku Haranaga; Masao Tateyama; Jiro Fujita; Mitsune Tanimoto; Huiping Li
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

3.  Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules.

Authors:  Hiromitsu Teruya; Mariko Tomita; Masachika Senba; Chie Ishikawa; Maki Tamayose; Akiko Miyazato; Satomi Yara; Yuetsu Tanaka; Yoichiro Iwakura; Jiro Fujita; Naoki Mori
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

4.  Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Authors:  Lloyd Einsiedel; Olivier Cassar; Emma Goeman; Tim Spelman; Virginia Au; Saba Hatami; Sheela Joseph; Antoine Gessain
Journal:  Open Forum Infect Dis       Date:  2014-05-28       Impact factor: 3.835

5.  Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.

Authors:  Lloyd Einsiedel; Tim Spelman; Emma Goeman; Olivier Cassar; Mick Arundell; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

6.  High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease.

Authors:  Shohreh Honarbakhsh; Graham P Taylor
Journal:  BMC Infect Dis       Date:  2015-07-06       Impact factor: 3.090

7.  Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.

Authors:  Lloyd Einsiedel; Hai Pham; Kim Wilson; Rebecca Walley; Jocelyn Turpin; Charles Bangham; Antoine Gessain; Richard J Woodman
Journal:  PLoS Negl Trop Dis       Date:  2018-03-12

Review 8.  Human T Lymphotropic Virus and Pulmonary Diseases.

Authors:  Apio R N Dias; Luiz F M Falcão; Aline S C Falcão; Valéria M F Normando; Juarez A S Quaresma
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

9.  Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.

Authors:  Lloyd Einsiedel; Hai Pham; Virginia Au; Saba Hatami; Kim Wilson; Tim Spelman; Hubertus Jersmann
Journal:  ERJ Open Res       Date:  2019-12-02

Review 10.  Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.

Authors:  Lloyd Einsiedel; Fabian Chiong; Hubertus Jersmann; Graham P Taylor
Journal:  Retrovirology       Date:  2021-01-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.